Recruiting
Phase 2

Irinotecan & FOLFOX

Sponsor:

Alliance for Clinical Trials in Oncology

Code:

NCT05610163

Conditions

Locally Advanced Rectal Carcinoma

Stage II Rectal Cancer AJCC V8

Stage III Rectal Cancer AJCC V8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Capecitabine

5-fluorouracil

Leucovorin calcium

Irinotecan

Oxaliplatin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information